Loading clinical trials...
Loading clinical trials...
Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia With Identical GVHD Prophylaxis - A Randomized Prospective European Trial.
Conditions
Interventions
Allogeneic Stem Cell Transplantation
Locations
24
Austria
LKH-Univ. Klinikum Graz
Graz, Austria
Medizinische Universität Innsbruck
Innsbruck, Austria
Medizinische Universität Wien, Universitätsklinik für Innere Medizin I Einrichtung für Stammzelltransplantation KMT
Vienna, Austria
Institute of Hematology and Blood Transfusion
Prague, Czechia
Turku University Central Hospital
Turku, Finland
University Hospital Düsseldorf
Düsseldorf, Germany
Start Date
November 14, 2019
Primary Completion Date
November 22, 2026
Completion Date
November 26, 2026
Last Updated
April 22, 2025
NCT06303193
NCT06847867
NCT06439199
NCT07216443
NCT06656494
NCT05588154
Lead Sponsor
Universitätsklinikum Hamburg-Eppendorf
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions